Collaboration Details

Title of Collaborative Activity:

Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)

Description of Collaborative Activity:

The Committee reviews and evaluates data on the safety and effectiveness of marketed and investigational human drug products for use in the practice of osteoporosis and metabolic bone disease, obstetrics, gynecology, urology and related specialties, and makes appropriate recommendations to the Commissioner of Food and Drugs.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

NIH Participating Institutes/Centers/Office of the Director:

NICHD

HHS Agency Collaborators on this Activity:

FDA